Correction: Regulator of G protein signaling 5 protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload (Proc Natl Acad Sci USA (2010) 107 (13818–13823) DOI: 10.1073/pnas.1008397107);Regulator of G protein signaling 5 protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 31, 2010, Pages 13818-13823

  Li, Hongliang ^a,b   He, Chengwei ^c   Feng, Jinhua ^a,b   Zhang, Yan ^a,b   Tang, Qizhu ^a,b   Bian, Zhouyan ^a,b   Bai, Xue ^a,b   Zhou, Heng ^a,b   Jiang, Hong ^a,b   Heximer, Scott P ^d   Qin, Mu ^a,b   Huang, He ^a,b   Liu, Peter P ^e   Huang, Congxin ^a,b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

ERK1 2; MEK1 2; RGS5; Signal transduction

Indexed keywords

MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN RGS 5; RGS PROTEIN; UNCLASSIFIED DRUG; RGS5 PROTEIN, HUMAN; RGS5 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; FIBROSIS; HEART VENTRICLE HYPERTROPHY; MONKEY; MOUSE; NONHUMAN; NORTHERN BLOTTING; PHENOTYPE; PRESSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STRESS; TRANSGENIC MOUSE; ANIMAL; ANTIBODY SPECIFICITY; CARDIOMEGALY; CELL CULTURE; GENETICS; MECHANICAL STRESS; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGICAL STRESS; RAT;

MUS; MUS MUSCULUS;

ANIMALS; CARDIOMEGALY; CELLS, CULTURED; FIBROSIS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, KNOCKOUT; ORGAN SPECIFICITY; PRESSURE; RATS; RGS PROTEINS; STRESS, MECHANICAL; STRESS, PHYSIOLOGICAL;

EID: 77956386624     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1804573115     Document Type: Erratum

References (20)

1. Berk BC, Fujiwara K, Lehoux S (2007) ECM remodeling in hypertensive heart disease. J Clin Invest 117:568-575.
2. Wencker D, et al. (2003) A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest 111:1497-1504.
3. Manzur M, Ganss R (2009) Regulator of G protein signaling 5: A new player in vascular remodeling. Trends Cardiovasc Med 19:26-30.
4. Gu S, Cifelli C, Wang S, Heximer SP (2009) RGS proteins: Identifying new GAPs in the understanding of blood pressure regulation and cardiovascular function. Clin Sci (Lond) 116:391-399.
5. Hamzah J, et al. (2008) Vascular normalization in Rgs5-deficient tumours promotes immune destruction. Nature 453:410-414.
6. Xiao B, Zhang Y, Niu WQ, Gao PJ, Zhu DL (2009) Haplotype-based association of regulator of G-protein signaling 5 gene polymorphisms with essential hypertension and metabolic parameters. Clin Chem Lab Med 47:1483-1488.
7. Cho H, et al. (2008) Rgs5 targeting leads to chronic low blood pressure and a lean body habitus. Mol Cell Biol 28:2590-2597.
8. Nisancioglu MH, et al. (2008) Generation and characterization of rgs5 mutant mice. Mol Cell Biol 28:2324-2331.
9. Jean-Baptiste G, et al. (2005) Beta adrenergic receptor-mediated atrial specific up-regulation of RGS5. Life Sci 76:1533-1545.
10. Lorenz K, Schmitt JP, Vidal M, Lohse MJ (2009) Cardiac hypertrophy: targeting Raf/MEK/ERK1/2-signaling. Int J Biochem Cell Biol 41:2351-2355.
11. Molkentin JD (2004) Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. Cardiovasc Res 63:467-475.
12. Molkentin JD, Dorn GW, 2nd (2001) Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol 63:391-426.
13. Bueno OF, Molkentin JD (2002) Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ Res 91:776-781.
14. Nakamura T, et al. (2007) Mediating ERK 1/2 signaling rescues congenital heart defects in a mouse model of Noonan syndrome. J Clin Invest 117:2123-2132.
15. Cho H, Kozasa T, Bondjers C, Betsholtz C, Kehrl JH (2003) Pericyte-specific expression of Rgs5: Implications for PDGF and EDG receptor signaling during vascular maturation. FASEB J 17:440-442.
16. Li HL, et al. (2007) Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice. Hypertension 49:1399-1408.
17. Li HL, et al. (2007) Targeted cardiac overexpression of A20 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction. Circulation 115:1885-1894.
18. Bian ZY, et al. (2010) LIM and cysteine-rich domains 1 regulates cardiac hypertrophy by targeting calcineurin/nuclear factor of activated T cells signaling. Hypertension 55:257-263.
19. Cai J, et al. (2009) Targeted expression of receptor-associated late transducer inhibits maladaptive hypertrophy via blocking epidermal growth factor receptor signaling. Hypertension 53:539-548.
20. Li HL, et al. (2006) Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways. Free Radic Biol Med 40:1756-1775.